Amexdrug Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AXRX research report →
Price Chart
About the company
Amexdrug Corporation, founded in 1963 and headquartered in Commerce, California, operates as a pharmaceutical and cosmeceutical enterprise. Primarily, the company, via its subsidiaries, distributes pharmaceutical products. Beyond this core function, Amexdrug is also deeply involved in the entire lifecycle of pharmaceutical drugs, cosmetics, and medical devices, from their research and development phases through manufacturing and ultimate sale.
- CEO
- Jack Amin
- IPO
- 2001
- Employees
- 9
- HQ
- Commerce, CA, US
Get TickerSpark's AI analysis on AXRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $33.88K
- P/E
- 0.50
- PEG
- 0.00
- P/S
- 0.01
- P/B
- 0.02
- EV/EBITDA
- 2.63
- Div Yield
- 0.00%
- Gross Margin
- 38.48%
- Op Margin
- 5.29%
- Net Margin
- 1.59%
- ROE
- 2.52%
- ROIC
- 6.76%
Latest fiscal year · YoY change
- Revenue
- $2.90M-14.6%
- Gross Profit
- $1.15M+6.9%
- Op Income
- $136.79K
- Net Income
- $40.27K+252.2%
- EPS
- $0.00+100.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.55
- RSI (14)
- 47
- Avg Volume
- 35
No earnings-call transcripts are available for AXRX yet.
- Free Float
- 3.4%
- Shares Outstanding
- 169.41M
- Float Shares
- 5.80M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 12, 12 | Tambi Brian | other | 5,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AXRX coverage
Recent articles, reports, and earnings notes.
No research on AXRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AXRX report →